Sprott Uranium Miners ETF vs 22nd Century Group Inc — how do they compare? Sprott Uranium Miners ETF trades at $46.5 (market cap $1.87B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Sprott Uranium Miners ETF is far larger — about 3008× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (45,625 versus 1,586,926). Which is the better fit depends on your goals — on Pluang, investors hold Sprott Uranium Miners ETF for 61 Days and 22nd Century Group Inc for 32 Days on average.
| URNM | XXII | |
|---|---|---|
Market Cap | $1.87B | $621.67K |
Volume | 1,586,926 | 45,625 |
Sector | Commodities - Metals/Agriculture | Consumer Staples |
52-Week High | $83.99 | $483.00 |
52-Week Low | $46.09 | $0.80 |
Typical Hold Time | 61 Days | 32 Days |
Enterprise Value | — | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
URNM trades at $46.50, down 2.86% today amid bearish technical signals with 19 sell indicators versus 4 buy. The ETF faces resistance near $47 while finding support at $45-46 levels. Recent news highlights uranium's long-term growth potential driven by AI energy demand and nuclear expansion, though short-term volatility persists.
The uranium mining ETF benefits from structural supply deficits and government nuclear investments, but faces near-term price pressure. Key risks include commodity price volatility and execution challenges among constituent miners. Analyst sentiment remains mixed with bullish long-term themes offset by technical weakness.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →